Efficacy and Safety of Chronic Administration of Telmisartan as Monotherapy or in Combination With Hydrochlorothiazide or Other Antihypertensive Medications in Patients With Mild to Moderate Hypertension

NCT02177422 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

489

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: Telmisartan
DRUG: Hydrochlorothiazide

Sponsor

Boehringer Ingelheim